$RZLT
Rezolute, Inc. Stock $rzlt

$rzlt Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000114420416082181 Filed on February 16, 2016

Income Statement

Concept	2015 Q4	2014 Q4
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.490M	$1.390M
YoY Change	7.19%	107.46%
% of Gross Profit
Research & Development	$2.524M	$1.566M
YoY Change	61.15%
% of Gross Profit
Depreciation & Amortization	$150.2K	$30.51K
YoY Change	392.33%
% of Gross Profit
Operating Expenses	$4.067M	$3.069M
YoY Change	32.5%	372.07%
Operating Profit	-$4.067M	-$3.069M
YoY Change	32.5%	372.07%
Interest Expense	$1.379K	$2.299K
YoY Change	-40.02%	-99.63%
% of Operating Profit
Other Income/Expense, Net	$543.00	$133.5K
YoY Change	-99.59%	-111.42%
Pretax Income	-$4.070M	-$2.940M
YoY Change	38.44%	61.54%
Income Tax
% Of Pretax Income
Net Earnings	-$4.066M	-$2.936M
YoY Change	38.51%	61.42%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$8.306M	-$7.737M
COMMON SHARES
Basic Shares Outstanding		18.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.710M	$8.590M
YoY Change	-80.09%	653.51%
Cash & Equivalents	$1.710M	$8.590M
Short-Term Investments
Other Short-Term Assets	$130.0K	$66.79K
YoY Change	94.64%	378.12%
Inventory		$76.14K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.840M	$8.733M
YoY Change	-78.93%	369.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.070M	$1.178M
YoY Change	415.35%	320.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$560.0K	$750.0K
YoY Change	-25.33%
Total Long-Term Assets	$6.690M	$1.987M
YoY Change	236.67%	593.23%
TOTAL ASSETS
Total Short-Term Assets	$1.840M	$8.733M
Total Long-Term Assets	$6.690M	$1.987M
Total Assets	$8.530M	$10.72M
YoY Change	-20.43%	399.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.220M	$1.060M
YoY Change	109.43%	121.99%
Accrued Expenses	$10.00K	$10.00K
YoY Change	0.0%	-98.33%
Deferred Revenue
YoY Change
Short-Term Debt	$60.00K	$60.00K
YoY Change	0.0%	-98.39%
Long-Term Debt Due	$70.00K	$90.00K
YoY Change	-22.22%
Total Short-Term Liabilities	$2.490M	$2.371M
YoY Change	5.0%	-63.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$70.00K
YoY Change	-100.0%
Other Long-Term Liabilities	$460.0K	$464.0K
YoY Change	-0.87%
Total Long-Term Liabilities	$460.0K	$534.7K
YoY Change	-13.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.490M	$2.371M
Total Long-Term Liabilities	$460.0K	$534.7K
Total Liabilities	$2.953M	$2.906M
YoY Change	1.61%	-55.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.46M	-$22.90M
YoY Change	59.25%
Common Stock	$24.34K	$22.00K
YoY Change	10.62%	-44.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.778M	$7.817M
YoY Change
Total Liabilities & Shareholders Equity	$8.535M	$10.72M
YoY Change	-20.41%	399.73%

Cashflow Statement

Concept	2015 Q4	2014 Q4
OPERATING ACTIVITIES
Net Income	-$4.066M	-$2.936M
YoY Change	38.51%	61.42%
Depreciation, Depletion And Amortization	$150.2K	$30.51K
YoY Change	392.33%
Cash From Operating Activities	-$2.290M	-$1.740M
YoY Change	31.61%	383.33%
INVESTING ACTIVITIES
Capital Expenditures	-$680.0K	-$150.0K
YoY Change	353.33%
Acquisitions
YoY Change
Other Investing Activities	$450.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$230.0K	-$150.0K
YoY Change	53.33%	1400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.870M	6.180M
YoY Change	-69.74%	309.27%
NET CHANGE
Cash From Operating Activities	-2.290M	-1.740M
Cash From Investing Activities	-230.0K	-150.0K
Cash From Financing Activities	1.870M	6.180M
Net Change In Cash	-650.0K	4.290M
YoY Change	-115.15%	276.32%
FREE CASH FLOW
Cash From Operating Activities	-$2.290M	-$1.740M
Capital Expenditures	-$680.0K	-$150.0K
Free Cash Flow	-$1.610M	-$1.590M
YoY Change	1.26%	341.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	198466	USD
CY2015Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	70526	USD
CY2015Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	114269	USD
CY2015Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	98671	USD
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	70526	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	24341	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40216691	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36463135	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29109288	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	3777897	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8534501	USD
CY2015Q2	us-gaap	Cash Cash	5278706	USD
CY2015Q4	us-gaap	Cash Cash	1708488	USD
CY2015Q4	us-gaap	Liabilities Liabilities	2953056	USD
CY2015Q2	us-gaap	Liabilities Liabilities	2209395	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2015Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	450167	USD
CY2015Q4	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	1142198	USD
CY2015Q4	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	340289	USD
CY2015Q4	us-gaap	Manufacturing Costs ManufacturingCosts	755464	USD
CY2015Q4	antb	Investor Relations InvestorRelations	57402	USD
CY2015Q4	antb	Consulting Fees ConsultingFees	0	USD
CY2015Q4	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	1170679	USD
CY2015Q4	us-gaap	Professional Fees ProfessionalFees	116112	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4066536	USD
CY2015Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	193	USD
CY2015Q4	us-gaap	Interest Expense InterestExpense	1379	USD
CY2015Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1729	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-4065993	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	539744	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	574923	USD
	us-gaap	Professional Fees ProfessionalFees	238173	USD
CY2015Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24338219	shares
	antb	Consulting Fees ConsultingFees	316633	USD
	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	2047532	USD
	us-gaap	Professional Fees ProfessionalFees	290069	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	543	USD
CY2014Q4	antb	Consulting Fees ConsultingFees	33000	USD
CY2014Q4	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	1034507	USD
CY2014Q4	us-gaap	Professional Fees ProfessionalFees	135724	USD
CY2014Q4	us-gaap	Operating Expenses OperatingExpenses	3069026	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	4066536	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3069026	USD
CY2014Q4	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	183872	USD
CY2014Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	1275	USD
CY2014Q4	us-gaap	Interest Expense InterestExpense	2299	USD
CY2014Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	134482	USD
CY2014Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	133458	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-2935568	USD
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2015Q4	antb	Facilities And Other Costs FacilitiesAndOtherCosts	285926	USD
CY2014Q4	antb	Facilities And Other Costs FacilitiesAndOtherCosts	165825	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	403649	USD
	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	678554	USD
	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	259419	USD
	antb	Investor Relations InvestorRelations	431445	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12288	USD
	us-gaap	Operating Expenses OperatingExpenses	5304144	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5304144	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2969	USD
	us-gaap	Interest Expense InterestExpense	2799	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	153714	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	153884	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5150260	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18511378	shares
	antb	Facilities And Other Costs FacilitiesAndOtherCosts	504951	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2846828	USD
CY2015	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	368419	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1965993	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	6026070	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4768123	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-11362364	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	6406731	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	111944	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1609	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3646	USD
	us-gaap	Depreciation Depreciation	57908	USD
	us-gaap	Depreciation Depreciation	220537	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1155521	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1965993	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	298418	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3208153	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4798290	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	2655409	USD
	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	2007401	USD
	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	604280	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	1375511	USD
	antb	Investor Relations InvestorRelations	114320	USD
	antb	Consulting Fees ConsultingFees	0	USD
	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	2117850	USD
	us-gaap	Operating Expenses OperatingExpenses	7366135	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7366135	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	964	USD
	us-gaap	Interest Expense InterestExpense	2992	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	14316	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7353847	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24338219	shares
	antb	Facilities And Other Costs FacilitiesAndOtherCosts	165825	USD
	antb	Warrant Expense WarrantExpense	84558	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	1257542	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-619875	USD
	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	-187500	USD
	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	-3570218	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-208962	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1000	USD
	antb	Deferred Lease Liability DeferredLeaseLiability	77351	USD
	antb	Deferred Lease Liability DeferredLeaseLiability	-4098	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6184606	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1847947	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-321044	USD
	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	22383	USD
	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	46453	USD
	antb	Warrant Expense WarrantExpense	21092	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-230101	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-65738	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-450167	USD
CY2014Q2	us-gaap	Cash Cash	5934534	USD
CY2014Q4	us-gaap	Cash Cash	8589943	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	266044	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	398317	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	295965	USD
CY2015Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	17461	USD
	antb	Fair Value Of Financial Instruments Earnings FairValueOfFinancialInstrumentsEarnings	14316	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	355825	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	136629	USD
CY2015Q4	us-gaap	Depreciation Depreciation	150225	USD
CY2014Q4	us-gaap	Depreciation Depreciation	30513	USD
	antb	Consulting Expenses ConsultingExpenses	66000	USD
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	138888	shares
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9511243	USD
CY2015	antb	Fair Value Of Warrants FairValueOfWarrants	31777	USD
	antb	Fair Value Of Warrants FairValueOfWarrants	17461	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	105000	shares
CY2015Q4	antb	Class Of Warrant Exercisable Warrants Or Rights ClassOfWarrantExercisableWarrantsOrRights	6000	shares
	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	187500	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	392855	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	335747	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	180628	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	48619	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	24223	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	72842	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	2316	USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Use of Estimates</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong> </strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives of depreciable assets, the fair value of share-based payments and warrants, fair value of derivative instruments, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	31777	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6429305	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4661541	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24338219	shares
CY2014Q4	antb	Consulting Expenses ConsultingExpenses	33000	USD
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24338219	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24338219	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24338219	shares
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2523877	USD
CY2014Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1566163	USD
CY2015Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1542659	USD
CY2014Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1502863	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	55000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6925543	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	105715	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	718554	USD
	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	90852	USD
	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	1180995	USD
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	2000115	USD
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0191	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1660842	USD
	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Cancelled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsCancelledInPeriod	30000	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 1 Nature of Operations</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">These financial statements represent the consolidated financial statements of AntriaBio, Inc. (“AntriaBio”), formerly known as Fits My Style, Inc., and its wholly owned operating subsidiary, AntriaBio Delaware, Inc. (“Antria Delaware”). AntriaBio and Antria Delaware are collectively referred to herein as the “Company”.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4	antb	Working Capital Deficit WorkingCapitalDeficit	649001	USD

Files In Submission

Name	View Source	Status
0001144204-16-082181-index-headers.html	Edgar Link	pending
0001144204-16-082181-index.html	Edgar Link	pending
0001144204-16-082181.txt	Edgar Link	pending
0001144204-16-082181-xbrl.zip	Edgar Link	pending
antb-20151231.xml	Edgar Link	completed
antb-20151231.xsd	Edgar Link	pending
antb-20151231_cal.xml	Edgar Link	unprocessable
antb-20151231_def.xml	Edgar Link	unprocessable
antb-20151231_lab.xml	Edgar Link	unprocessable
antb-20151231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v430207_10q.htm	Edgar Link	pending
v430207_ex10-1.htm	Edgar Link	pending
v430207_ex31-1.htm	Edgar Link	pending
v430207_ex31-2.htm	Edgar Link	pending
v430207_ex32-1.htm	Edgar Link	pending
v430207_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RZLT
Rezolute, Inc. Stock $rzlt

2015 Q4 Form 10-Q Financial Statement

#000114420416082181 Filed on February 16, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT Rezolute, Inc. Stock $rzlt

2015 Q4 Form 10-Q Financial Statement

#000114420416082181 Filed on February 16, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT
Rezolute, Inc. Stock $rzlt